PrismaLung+ ECCO₂R
Mild-to-Moderate Acute Respiratory Distress Syndrome (ARDS)
Clinical Evidence GenerationActive
Key Facts
Indication
Mild-to-Moderate Acute Respiratory Distress Syndrome (ARDS)
Phase
Clinical Evidence Generation
Status
Active
Company
About Vantive
Vantive is a Boston-based, private healthcare company founded in 2019, emerging from a long-standing legacy in kidney care. It operates at the intersection of medical devices, digital health, and services, offering therapies for chronic and acute kidney disease alongside extracorporeal organ support. The company's strategy centers on integrating digital solutions and advanced services with its core therapeutic devices to improve patient care and expand access, particularly to home-based dialysis. Vantive is in a commercial stage, generating revenue from its established portfolio while actively developing and launching new innovations.
View full company profile